Search research articles
Contact Us
Filters
Showing results (261-270 of 272) with videos related to
Page
of 28
Sort By:
Plos One
|
March 10, 2015
A high-throughput in vitro drug screen in a genetically engineered mouse model of diffuse intrinsic pontine glioma identifies BMS-754807 as a promising therapeutic agent
Kyle G Halvorson, Kelly L Barton, Kristin Schroeder, et al.
Archivum Immunologiae Et Therapiae Experimentalis
|
March 19, 2022
Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients
Oscar J Cordero, Irene Viéitez, Irene Altabás, et al.
Revista Medica De Chile
|
January 1, 1996
[Experience of a single center in liver transplantation in adults and children]
E Buckel, G Silva, J Brahm, et al.
BMC Immunology
|
August 23, 2012
Serum activity of DPPIV and its expression on lymphocytes in patients with melanoma and in people with vitiligo
Ivana Z Matić, Marija Ðorđić, Nađa Grozdanić, et al.
Plos One
|
July 16, 2015
CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis
Oscar J Cordero, Rubén Varela-Calviño, Tania López-González, et al.
Clinical and Experimental Immunology
|
December 18, 2014
Characterization of the autoimmune response against the nerve tissue S100β in patients with type 1 diabetes
I Gómez-Touriño, R Simón-Vázquez, J Alonso-Lorenzo, et al.
Anales De Pediatria (Barcelona, Spain : 2003)
|
March 26, 2011
[Psychometric attributes of the Spanish version of A-TAC screening scale for autism spectrum disorders]
E Cubo, S Sáez Velasco, V Delgado Benito, et al.
Leukemia & Lymphoma
|
March 9, 2013
Dipeptidyl peptidase IV: serum activity and expression on lymphocytes in different hematological malignancies
Ivana Z Matić, Milica Đorđević, Marija Đorđić, et al.
Cancers
|
October 14, 2022
Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs
Loretta De Chiara, Leticia Barcia-Castro, María Gallardo-Gómez, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)
|
September 6, 2001
[The histological lesions of chronic hepatitis C as predicting factors of sustained response to the treatment with interferon]
E G Gento Peña, A López Morante, J Cordero Guevara, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 272) with videos related to
Sort By:
Page
of 28
Plos One
|
March 10, 2015
A high-throughput in vitro drug screen in a genetically engineered mouse model of diffuse intrinsic pontine glioma identifies BMS-754807 as a promising therapeutic agent
Kyle G Halvorson, Kelly L Barton, Kristin Schroeder, et al.
Archivum Immunologiae Et Therapiae Experimentalis
|
March 19, 2022
Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients
Oscar J Cordero, Irene Viéitez, Irene Altabás, et al.
Revista Medica De Chile
|
January 1, 1996
[Experience of a single center in liver transplantation in adults and children]
E Buckel, G Silva, J Brahm, et al.
BMC Immunology
|
August 23, 2012
Serum activity of DPPIV and its expression on lymphocytes in patients with melanoma and in people with vitiligo
Ivana Z Matić, Marija Ðorđić, Nađa Grozdanić, et al.
Plos One
|
July 16, 2015
CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis
Oscar J Cordero, Rubén Varela-Calviño, Tania López-González, et al.
Clinical and Experimental Immunology
|
December 18, 2014
Characterization of the autoimmune response against the nerve tissue S100β in patients with type 1 diabetes
I Gómez-Touriño, R Simón-Vázquez, J Alonso-Lorenzo, et al.
Anales De Pediatria (Barcelona, Spain : 2003)
|
March 26, 2011
[Psychometric attributes of the Spanish version of A-TAC screening scale for autism spectrum disorders]
E Cubo, S Sáez Velasco, V Delgado Benito, et al.
Leukemia & Lymphoma
|
March 9, 2013
Dipeptidyl peptidase IV: serum activity and expression on lymphocytes in different hematological malignancies
Ivana Z Matić, Milica Đorđević, Marija Đorđić, et al.
Cancers
|
October 14, 2022
Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs
Loretta De Chiara, Leticia Barcia-Castro, María Gallardo-Gómez, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)
|
September 6, 2001
[The histological lesions of chronic hepatitis C as predicting factors of sustained response to the treatment with interferon]
E G Gento Peña, A López Morante, J Cordero Guevara, et al.
Page
of 28